Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Earnings Scheduled For March 31, 2023

Author: Benzinga Insights | March 31, 2023 04:45am

Companies Reporting Before The Bell

• Pioneer Muni High Inc (NYSE:MAV) is likely to report quarterly earnings at $0.05 per share on revenue of $35.00 million.

• Bio-Path Holdings (NASDAQ:BPTH) is likely to report earnings for its fourth quarter.

• Crown ElectroKinetics (NASDAQ:CRKN) is estimated to report earnings for its fourth quarter.

• Carlyle Group (NASDAQ:CG) is likely to report earnings for its first quarter.

• Chemomab Therapeutics (NASDAQ:CMMB) is expected to report earnings for its fourth quarter.

• P3 Health Partners (NASDAQ:PIII) is expected to report quarterly loss at $0.91 per share on revenue of $252.95 million.

• Bioventus (NASDAQ:BVS) is projected to report quarterly earnings at $0.05 per share on revenue of $132.70 million.

• Creative Media (NASDAQ:CMCT) is likely to report quarterly loss at $0.16 per share on revenue of $25.22 million.

• PyroGenesis Canada (NASDAQ:PYR) is likely to report earnings for its fourth quarter.

• Nuvve Holding (NASDAQ:NVVE) is likely to report quarterly loss at $0.32 per share on revenue of $800 thousand.

• Strata Skin Sciences (NASDAQ:SSKN) is projected to report quarterly loss at $0.05 per share on revenue of $9.82 million.

• Tivic Health Systems (NASDAQ:TIVC) is estimated to report quarterly loss at $0.31 per share on revenue of $640 thousand.

• Alarum Technologies (NASDAQ:ALAR) is likely to report quarterly loss at $0.78 per share on revenue of $5.03 million.

• Alimera Sciences (NASDAQ:ALIM) is projected to report quarterly loss at $0.33 per share on revenue of $14.62 million.

• Data Storage (NASDAQ:DTST) is expected to report earnings for its fourth quarter.

• BIO-key Intl (NASDAQ:BKYI) is estimated to report quarterly loss at $0.27 per share on revenue of $1.74 million.

• Harbor Custom Dev (NASDAQ:HCDI) is likely to report quarterly loss at $3.40 per share on revenue of $12.60 million.

• Advent Technologies Hldgs (NASDAQ:ADN) is estimated to report earnings for its fourth quarter.

• I-MAB (NASDAQ:IMAB) is estimated to report earnings for its Fiscal Year 2022.

• Fathom Digital Mfg (NYSE:FATH) is projected to report quarterly loss at $0.01 per share on revenue of $40.48 million.

Companies Reporting After The Bell

• Chicken Soup for the Soul (NASDAQ:CSSE) is expected to report quarterly loss at $1.17 per share on revenue of $112.34 million.

• Kidpik (NASDAQ:PIK) is estimated to report quarterly loss at $0.32 per share on revenue of $3.70 million.

• AIM ImmunoTech (AMEX:AIM) is likely to report quarterly loss at $0.12 per share on revenue of $180 thousand.

• bioAffinity Technologies (NASDAQ:BIAF) is estimated to report earnings for its fourth quarter.

• Electra Battery Materials (NASDAQ:ELBM) is likely to report earnings for its fourth quarter.

• Inhibikase Therapeutics (NASDAQ:IKT) is likely to report earnings for its fourth quarter.

• Applied UV (NASDAQ:AUVI) is estimated to report quarterly loss at $0.18 per share on revenue of $5.50 million.

• MSP Recovery (NASDAQ:LIFW) is expected to report quarterly earnings at $0.69 per share on revenue of $303.98 million.

• Williams Ind Servs (AMEX:WLMS) is estimated to report quarterly loss at $0.35 per share on revenue of $54.50 million.

• Verb Tech (NASDAQ:VERB) is projected to report quarterly loss at $0.05 per share on revenue of $2.61 million.

• VirTra (NASDAQ:VTSI) is expected to report quarterly loss at $0.01 per share on revenue of $6.64 million.

• Flexible Solutions Intl (AMEX:FSI) is estimated to report quarterly earnings at $0.10 per share on revenue of $10.41 million.

• Eastside Distilling (NASDAQ:EAST) is expected to report quarterly loss at $0.17 per share on revenue of $3.66 million.

• Miromatrix Medical (NASDAQ:MIRO) is expected to report earnings for its fourth quarter.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADN ALAR ALIM AUVI BIAF BKYI BPTH BVS CG CMCT CMMB CRKN CSSE DTST EAST ELBM FATH HCDI IKT IMAB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist